We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Yeast Study Performs Hundreds of Simultaneous CRISPR Edits

News   May 22, 2018 | Original Press Release from the Wyss Institute

 
Yeast Study Performs Hundreds of Simultaneous CRISPR Edits

team at Harvard’s Wyss Institute has developed a CRISPR-Cas9-based strategy that is able to generate and profile hundreds of precise mutations in the genome with high throughput. Credit: Shutterstock

 
 
 

RELATED ARTICLES

Immunotherapy Opportunities Lie in Glioma Molecular Landscape

News

A slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

READ MORE

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE